Young Voices United against CRC
16 Jul 2012
Young Voices United against CRC
The WINTHER study
Drugging the cancer genome: opportunities and challenges
The involvement of rare cancer patients in clinical research
Application of next generation sequencing
Next generation sequencing and WIN therapeutics
Importance of early detection and the ‘Beyond the Shock’ programme
Shortening the timeline for clinical drug developments
Building international collaborations and the WINTHER trial
Addressing the problem of adherence to treatment
Patient and doctor communication and quality of life guidelines
President's overview of ASCO 2012